Login
- Title:
Labeling human embryonic stem-cell-derived cardiomyocytes for tracking with MR imaging.
- Document type:
- journal article
- Author(s):
- Castaneda, RT; Boddington, S; Henning, TD; Wendland, M; Mandrussow, L; Liu, S; Daldrup-Link, H
- Abstract:
- Human embryonic stem cells (hESC) can generate cardiomyocytes (CM), which offer promising treatments for cardiomyopathies in children. However, challenges for clinical translation result from loss of transplanted cell from target sites and high cell death. An imaging technique that noninvasively and repetitively monitors transplanted hESC-CM could guide improvements in transplantation techniques and advance therapies.To develop a clinically applicable labeling technique for hESC-CM with FDA-approved superparamagnetic iron oxide nanoparticles (SPIO) by examining labeling before and after CM differentiation.Triplicates of hESC were labeled by simple incubation with 50 ?g/ml of ferumoxides before or after differentiation into CM, then imaged on a 7T MR scanner using a T2-weighted multi-echo spin-echo sequence. Viability, iron uptake and T2-relaxation times were compared between groups using t-tests.hESC-CM labeled before differentiation demonstrated significant MR effects, iron uptake and preserved function. hESC-CM labeled after differentiation showed no significant iron uptake or change in MR signal (P< 0.05). Morphology, differentiation and viability were consistent between experimental groups.hESC-CM should be labeled prior to CM differentiation to achieve a significant MR signal. This technique permits monitoring delivery and engraftment of hESC-CM for potential advancements of stem cell-based therapies in the reconstitution of damaged myocardium.
- Journal title abbreviation:
- Pediatr Radiol
- Year:
- 2011
- Journal volume:
- 41
- Journal issue:
- 11
- Pages contribution:
- 1384-92
- Language:
- eng
- Pubmed ID:
- http://view.ncbi.nlm.nih.gov/pubmed/21594541
- Print-ISSN:
- 0301-0449
- TUM Institution:
- Röntgendiagnostik
BibTeX